5.26
price up icon0.57%   0.03
after-market Handel nachbörslich: 5.31 0.05 +0.95%
loading

Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
14.57%
8.5052
7.4233 12.44 14.97 6.1835
Operating Income/Loss
2.48%
-10.17
-10.43 -16.14 -18.01 -9.3939
Nonoperating Income/Loss
19.39%
0.4014
0.498 1.0246 1.1602 1.3117
Income/Loss From Continuing Operations Before Tax
1.63%
-9.7673
-9.9295 -15.11 -16.85 -8.0821
Income/Loss From Continuing Operations After Tax
1.63%
-9.7673
-9.9295 -15.11 -16.85 -8.0821
Net Income/Loss
1.63%
-9.7673
-9.9295 -15.11 -16.85 -8.0821
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.26%
60.05
59.89 59.53 59.41 59.41
Diluted Average Shares
0.26%
60.05
59.89 59.53 59.41 59.41
Basic Earnings Per Share
5.88%
-0.16
-0.17 -0.25 -0.28 -0.14
Diluted Earnings Per Share
5.88%
-0.16
-0.17 -0.25 -0.28 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.54
price down icon 0.53%
$31.40
price up icon 1.88%
$105.55
price down icon 0.65%
$99.71
price up icon 3.28%
biotechnology ONC
$335.17
price up icon 0.74%
$209.02
price up icon 1.01%
Kapitalisierung:     |  Volumen (24h):